# Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone

> **NCT07314346** · PHASE1 · RECRUITING · sponsor: **Atea Pharmaceuticals, Inc.** · enrollment: 32 (estimated)

## Conditions studied

- Healthy Volunteer Study

## Interventions

- **DRUG:** Buprenorphine/Naloxone + BEM/RZR
- **DRUG:** Methadone +BEM/RZR

## Key facts

- **NCT ID:** NCT07314346
- **Lead sponsor:** Atea Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-07
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07314346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07314346, "Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07314346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*